Zobrazeno 1 - 7
of 7
pro vyhledávání: '"James E. Leonard"'
Autor:
John W. Davison, Melissa C. Fraine, Mary H. Thornquist, Christopher W. Loftis, James E. Leonard
Publikováno v:
Journal of Traumatic Stress. 33:267-275
In the present study, we examined administrative data on 667,437 deployments of at least 30 days duration to Iraq and Afghanistan from 2011 through the end of 2016 to determine risk factors for evacuation from the combat zone for behavioral health re
Publikováno v:
The Journal of antibiotics. 49(5)
Autor:
James E. Leonard
Publikováno v:
Journal of Endodontics. 20:422
Autor:
Momir Cirovic, Ruth S. Stanaszek, Paul Kurath, Richard S. Egan, William H. Washburn, James E. Leonard, Dave Grampovnik, Paulette Johnson, Jack Tadanier
Publikováno v:
The Journal of Antibiotics. 34:691-700
The preparation of 4-de-N-methylfortimicin A analogs as well as the preparation of 4-de-N-methyl-4-N-(beta-aminoethyl)-4-N-ethylfortimicin B is reported. It was shown that the 4-N-methyl group in fortimicin analogs is essential for antibacterial acti
Autor:
P. L. Rittenhouse, R. A. Dean, A. D. Emery, D. B. Scott, J. R. Stewart, D. O. Hobson, M. F. Osborne, G. W. Parker, R. D. Waddell, F. A. Lorenz, B. E. Bingham, A. L. Lowe, Wayne A. Carbiener, Richard G. Bock, John D. Ducan, James E. Leonard, J. E. Hench, D. J. Liffengren, P.R. Davis, J. O. Cermak, R.H. Leyse, D. P. Dominicis, John T. Mihalczo, Jon A. Reuscher, R.M. Carroll, O. Sisman, C. Z. Serpan, H.E. Watson, R.M. Collins, R. D. Baybarz, J. B. Knauer, J. R. Peterson
Publikováno v:
Nuclear Technology. 11:468-472
Publikováno v:
Nuclear Technology. 11:532-543
Autor:
Dave Grampovnik, Richard S. Egan, Daniel A. Dunnigan, Paulette Johnson, Paul Kurath, Preston Hill, Ruth S. Stanaszek, William H. Washburn, James E. Leonard, Momir Cirovic, Jerry R. Martin, Jack Tadanier, Alma W. Goldstein
Publikováno v:
The Journal of antibiotics. 32(9)
The conversion of fortimicin E, a minor metabolite from the Micromonospora olivoasterospora fermentation which also produces fortimicin A and fortimicin B, to four 4-N-aminoacylfortimicins E was accomplished. The new 4-N-aminoacylfortimicins E showed